Apple Inc (AAPL) Falls 6.16% for January 27

Equities Staff |

One of the S&P 500’s big losers for Wednesday January 27 was Apple Inc (AAPL). The company’s stock fell 6.16% to $93.83 on volume of 117.12 million shares.

The stock opened the day at 96.04 and traded between a low of $93.65 and a high of $96.63. The stock finished the day down $6.1604 per share. Apple Inc has an average daily volume of 48.61 million and a total float of 5.58 billion shares. The 50-day SMA for Apple Inc is $108.91 and its 200-day SMA is $117.28. The high for the stock over the last 52 weeks is $134.54 and the low is $92.00.

Apple Inc designs, manufactures, & markets mobile communication & media devices, personal computers, & portable digital music players, & sells a variety of related software, services, accessories, networking solutions, & third-party digital content.

Apple Inc is centered in Cupertino, CA, and has 110,000 employees. Today’s trading day leaves the company with a market cap of $523.13 billion. The company has a P/S ratio of n/a, P/B ratio of 4.38, and a 18.4.

For a complete fundamental analysis analysis of Apple Inc, check out’s Stock Valuation Analysis report for AAPL. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Pressure Biosciences Inc

Pressure BioSciences Inc is a biological life sciences research company. It is engaged in the development and commercialization of a platform technology called pressure cycling technology.

Private Markets


The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…